Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0300
+0.0020 (7.14%)
At close: Oct 9, 2026
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $7.95 million as of October 9, 2026. It is the 42,911th most valuable company in the world and the 5,787th biggest in the United States. Its market cap has decreased by 85.75% in one year.
Market Cap
7.95M
Enterprise Value
-3.92M
Revenue
5.92M
Global Rank
Country Rank
#5,787 United States
PE Ratio
0.32
ChartMarket Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 7.95M, a decrease of -99.35%. That is a compound annual growth rate of -35.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 7.95M | 15.38% |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 10.08M |
| Oncotelic Therapeutics | 9.61M |
| Zeo ScientifiX | 9.40M |
| OSR Health | 7.37M |
| Curative Biotechnology | 7.15M |
| LianMedical | 6.54M |
| Reviva Pharmaceuticals Holdings | 6.49M |
| TRON Group | 6.44M |